Ziegler Capital Management, LLC Staar Surgical CO Transaction History

Ziegler Capital Management, LLC

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 25, 2023	SELL	$50.45 - $72.82 $85,462 - $123,357	-1,694 Reduced 1.48%	112,869 $5.93 Million
Q1 2023 May 04, 2023	SELL	$51.25 - $79.34 $61,910 - $95,842	-1,208 Reduced 1.04%	114,563 $7.33 Million
Q4 2022 Jan 24, 2023	SELL	$46.82 - $76.2 $222,722 - $362,483	-4,757 Reduced 3.95%	115,771 $0
Q3 2022 Oct 25, 2022	SELL	$70.55 - $111.58 $139,124 - $220,035	-1,972 Reduced 1.61%	120,528 $8.5 Million
Q2 2022 Jul 21, 2022	SELL	$50.24 - $80.48 $2,260 - $3,621	-45 Reduced 0.04%	122,500 $8.69 Million
Q1 2022 May 04, 2022	BUY	$57.98 - $93.5 $1.46 Million - $2.35 Million	25,129 Added 25.8%	122,545 $9.79 Million
Q4 2021 Feb 09, 2022	SELL	$88.02 - $127.79 $49,731 - $72,201	-565 Reduced 0.58%	97,416 $8.89 Million
Q3 2021 Oct 27, 2021	BUY	$122.75 - $162.68 $6.65 Million - $8.82 Million	54,194 Added 123.77%	97,981 $12.6 Million
Q2 2021 Jul 21, 2021	SELL	$105.76 - $154.96 $7.67 Million - $11.2 Million	-72,531 Reduced 62.36%	43,787 $17.1 Million
Q1 2021 Apr 29, 2021	SELL	$78.5 - $126.48 $150,563 - $242,588	-1,918 Reduced 1.62%	116,318 $12.3 Million
Q4 2020 Feb 05, 2021	SELL	$55.93 - $82.78 $1.84 Million - $2.72 Million	-32,814 Reduced 21.72%	118,236 $9.37 Million
Q3 2020 Oct 21, 2020	SELL	$45.65 - $61.81 $3.52 Million - $4.76 Million	-77,000 Reduced 33.76%	151,050 $8.54 Million
Q2 2020 Jul 24, 2020	BUY	$29.15 - $61.54 $1.96 Million - $4.14 Million	67,204 Added 41.78%	228,050 $14 Million
Q1 2020 Apr 30, 2020	BUY	$25.01 - $42.4 $4.02 Million - $6.82 Million	160,846 New	160,846 $5.19 Million

251

47.3M

427K

206K

Ticker STAA
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 48,038,300
Market Cap $1.15B
Description
STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides Visian implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatis...

Get notified when there are updates to the investment portfolio of Ziegler Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Ziegler Capital Management, LLC with notifications on news.